等待开盘 05-19 09:30:00 美东时间
+2.410
+5.08%
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
BTIG analyst Allan Verkhovski maintains Workiva (NYSE:WK) with a Buy and lowers the price target from $90 to $80.
05-06 20:12
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Workiva 2026年第一季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 总营收:2.47亿美元,同比增长20%,超出指导区间上限100万美元 - 订阅营收:2.25亿美元,同比增长21% - 专业服务营收:2200万美元,与去年同期基本持平,略有增长 **盈利能力:** - Non-GAAP营业利润率:18.4%,超出指导区间上限240个基点 - 毛利率:继续改善,接近中期目标水平 **现金流状况:** - 现金、现金等价物及有价证券:季末余额8300万美元 - 季度现金减少2800万美元,主要因股票
05-06 12:14
华盛资讯5月6日讯,Workiva Inc. Class A公布2026财年Q1业绩,公司Q1营收2.47亿美元,同比增长19.9%,归母净利润0.19亿美元,扭亏为盈。
05-06 08:40
华盛资讯5月6日讯,Workiva Inc. Class A公布2026财年Q1业绩,公司Q1营收2.47亿美元,同比增长19.9%,归母净利润0.19亿美元,扭亏为盈。
05-06 05:34
Workiva shares are trading lower. The company reported Q1 financial results.
05-06 04:40
Workiva (NYSE:WK) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.66 by 16.67 percent. This is a 450 percent increase over earnings of $0.14 per share from the same period
05-06 04:19
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Shares of companies in the broader software sector are trading lower amid a pul...
04-24 02:46
Shares of software-related companies are trading higher as the sector rebounds ...
04-14 01:06